Teagan Thomas, co-founder of iGem uOttawa and one of the team leads on this program, talks with Kristy Cameron about the biomanufacturing platform Phytogene and how they're leveraging it to help use tobacco plants to develop drugs similar to Ozempic and others as well as recent success at a competition in Paris.

<p>Teagan Thomas, co-founder of iGem uOttawa and one of the team leads on this program, talks with Kristy Cameron about the biomanufacturing platform Phytogene and how they're leveraging it to help use tobacco plants to develop drugs similar to Ozempic and others as well as recent success at a competition in Paris.</p>